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Abstract
Background: We previously showed, in healthy, middle-aged, moderately overweight men, that orange juice decreases
diastolic blood pressure and significantly improves postprandial microvascular endothelial reactivity and that hesperidin
could be causally linked to the observed beneficial effect of orange juice. The objective was to determine the effect of
chronic consumption of orange juice on the gene expression profile of leukocytes in healthy volunteers and to assess to
what extent hesperidin is involved in the effect of orange juice.
Methodology/Principal Findings: Volunteers were included in a randomized, controlled, crossover study. Throughout three
4-week periods, volunteers consumed daily: 500 ml orange juice, 500 ml control drink plus hesperidin or 500 ml control
drink and placebo. Blood samplings were performed on 10 overnight-fasted subjects after the 4-week treatment period.
Global gene expression profiles were determined using human whole genome cDNA microarrays. Both orange juice and
hesperidin consumption significantly affected leukocyte gene expression. Orange juice consumption induced changes in
expression of, 3,422 genes, while hesperidin intake modulated the expression of 1,819 genes. Between the orange juice and
hesperidin consumption groups, 1,582 regulated genes were in common. Many of these genes are implicated in
chemotaxis, adhesion, infiltration and lipid transport, which is suggestive of lower recruitment and infiltration of circulating
cells to vascular wall and lower lipid accumulation.
Conclusions: This study shows that regular consumption of orange juice for 4 weeks alters leukocyte gene expression to an
anti-inflammatory and anti-atherogenic profile, and hesperidin displays a relevant role in the genomic effect of this
beverage.
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Introduction
We previously showed, in healthy, middle-aged, but moderately
overweight men, that orange juice decreased diastolic blood
pressure and significantly improved postprandial microvascular
endothelial reactivity [1]. Furthermore, our study strongly
suggested that hesperidin, its major flavonoid, is causally linked
to the observed beneficial effect of orange juice. These vascular
protective effects of orange juice and the possible specific role of
hesperidin in mediating these effects are in agreement with a
recent prospective study that showed convincing results for an
association between the dietary intake of flavanones and
flavanone-rich foods and reduced risks of coronary heart diseases
[2]. Other clinical studies in healthy subjects have also shown that
orange juice consumption reduced oxidative DNA damage and
may prevent meal-induced oxidative and inflammatory stress in
circulating blood mononuclear cells [3,4]. The reduction of
reactive oxygen species generation and NF-kB binding following
orange juice intake could possibly be due to its flavonoid content,
as suggested by in vitro results. In fact, these changes occurred
when mononuclear cells were incubated with hesperetin, while
fructose or ascorbic acid did not cause any change [3].
Nevertheless, much remains to be done to advance the
understanding of the mechanisms by which the orange juice and
some of its constituents could exert protective health effects.
Nevertheless, much work remains in order to advance our
understanding of the mechanisms by which orange juice and
some of its constituents could exert protective health effects.
For some foods rich in flavonoids, such as tea or cocoa, the role
of these bioactive compounds in vascular protection has been
demonstrated in clinical trials [5,6], studies on animal models of
atherosclerosis and in in vitro studies using vascular cells [7,8].
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vascular cell function through the modulation of gene expression
and intracellular signaling pathways [9–11]. In addition, recent
findings from animal studies suggest that the actions of flavonoids
are related to their capacity to interact with the cellular signaling
cascades that regulate transcription factors and as a consequence,
expression of genes and proteins [12,13]. More recently,
transcriptome analysis of aortas from mice fed naringin revealed
that the anti-atherogenic effect of this grapefruit flavonoid might
be linked to changes in gene expression that play a role in the
preservation of the vascular wall [14].
Few human studies have shown the potential use of gene
expression profiling in blood leukocytes to study the effects of diet
on gene expression modulation. It has been proposed that
modulation of gene expression in these cells might be related to
the various clinical and biochemical changes that occur during
cardiovascular disease (CVD) development [15–17]. Nevertheless,
the nutrigenomic impact of dietary flavonoids has not been
extensively investigated. To our knowledge, only one recent study
has examined the effect of quercetin supplementation on the
human monocyte gene expression profile [18]. In our study,
cDNA microarrays were used to identify gene expression changes
in the white blood cells of healthy human volunteers after chronic
consumption of either orange juice or purified hesperidin. This
comparison aims to determine to what extent hesperidin is
implicated in the nutrigenomic effects of orange juice.
Materials and Methods
The protocol for this trial and supporting CONSORT checklist
are available as supporting information; see Checklist S1 and
Protocol S1.
The human intervention study
Subjects. Twenty-four overweight male volunteers, 50–65
years of age, were recruited by newspaper advertisements. All
subjects were healthy and had no evidence of chronic disease.
Exclusion criteria were as follows: use of medication, use of
antioxidants or vitamin supplements, smoking, alcohol
consumption (.20 g alcohol/d), intense physical activity (.5h /
wk), intestinal disorders and vegetarianism. Subjects presenting
with a high consumption of flavonoid-rich beverages, such as tea,
herb tea, coffee, wine, cocoa and fruit juice, were also excluded
when the daily consumption of one or more of these products
exceeded 500 ml (as estimated from food frequency
questionnaire). The study was approved by and performed
under the guidelines of the French Human Ethics Committee of
the South East VI. Written informed consent was obtained from
each of the subjects before commencement of the study. All
subjects completed the study except one who was excluded
because of concurrent disease. Each volunteer enrolled in the
study received 1130 euros. Clinical trial, settings and data
collection were performed at the clinical research unit.
Test drinks and products. The details regarding these
products were largely described previously [1]. Briefly, orange
juice from concentrate was provided by the Florida Department of
Citrus (Lake Alfred, FL, USA) and its hesperidin content was
292 mg/500 ml, corresponding to the daily administered dose.
The control drink had a sugar composition similar to that of
orange juice (Table S1), which made the two beverages isocaloric.
Hesperidin capsules were filled with the orange bioflavonoid
complex (OBC 90%) containing 99.2% hesperidin (Nutrafur,
Murcia, Spain). Each capsule contained 146 mg of OBC, which
corresponds to the amount of hesperidin in 250 ml orange juice.
Placebo capsules consisted of starch (146 mg/capsule) and were
visually identical to the hesperidin capsules.
Study design. The primary aim of the present randomized,
cross-over study was to assess the effect of orange juice and
hesperidin on endothelial and vessel function for which the results
have been published elsewhere [1], and the second outcome was to
examine the contribution of hesperidin in changes in gene
expression in circulating blood cells induced by orange juice
consumption. Briefly, the clinical study was a controlled,
randomized, crossover, 4-week dietary intervention trial with
three treatment groups: control drink+placebo, control
drink+hesperidin and orange juice. For the orange juice
intervention, the trial was open, but it was double-blinded for
control drink+placebo and control drink+hesperidin. A 3-week
washout period was applied between each treatment. A flow
diagram of the study design is presented in Figure 1. The order of
administration was determined using computer-generated random
numbers. The randomization is based on a randomized Latin
square to form six possible combinations from the three
treatments, and the six groups were balanced (4 subjects/group).
Randomization and implementation procedures were performed
by a person from the clinical investigation unit not involved in the
clinical trial.
Recruitment started on June 2007 and ended on September
2007, and the follow-up ended on February 2008. Each subject
was successively assigned to three periods of four-week dietary
treatments with a daily consumption of either: 1) 500 ml of a
control drink plus 2 placebo capsules, 2) 500 ml of the control
drink plus 2 capsules of pure hesperidin or 3) 500 ml of orange
juice, which naturally provides 292 mg hesperidin. At home,
subjects were instructed to divide the total daily dose into two
equal intakes, one with breakfast and the other at lunchtime. On
the first and last day of each experimental period, cardiovascular
measurements (blood pressure and microvascular reactivity) and
blood sample collections were performed on fasted volunteers. The
calculation of the number of subjects to include in the trial was
based on a statistical power $0.8, considering variability in laser
Doppler recordings observed in previous experiments conducted
in our laboratory to be between 16 and 21% and to have mean
significant difference of at least 15%. Statistical analyses have
performed using The PROC MIXED (SAS Institute) procedure
by using a mixed linear model as detailed in [1]. Among the 24
volunteers enrolled in the randomized controlled cross-over study,
12 volunteers, selected by drawing lots at the beginning of the trial,
participated in the present nutrigenomic study. This number of
volunteers has been chosen regarding several previous nutrige-
nomic studies in clinical trials in which the number of volunteers
varied from 3 to 15 [15,16,18,19].
Blood samples
Blood samples were collected, after an overnight fasting period,
from the 10 selected volunteers at the end of each 4-week dietary
intervention (control drink+placebo; control drink+hesperidin;
orange juice). White blood cells were obtained using the Leuko-
LOCK total RNA isolation system (Ambion, Austin, USA) as per
the manufacturer’s instructions. In brief, 9 ml of blood samples with
EDTA were passed through a LeukoLOCK Filter that captures
leukocytes (white blood cells). The filters were flushed with
phosphate-buffered saline (PBS) followed by RNAlater solution to
stabilize the leukocyte RNA and stored at 280uC until used.
RNA isolation
RNA was isolated using the LeukoLOCK total RNA isolation
system (Ambion, Austin, USA) as recommended by the manufac-
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in a guanidine thiocyanate-based solution that rapidly releases
total RNA. A brief proteinase K treatment was performed to
degrade cellular proteins. Total RNA was purified using magnetic
beads, and a DNase treatment was performed to remove genomic
DNA. The quality of obtained total RNA was verified by
Figure 1. The flow diagram of the study.
doi:10.1371/journal.pone.0026669.g001
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was determined (Thermo Scientific NanoDropTM). Using this
approach, we obtained good quality total RNA from 30 samples at
an average concentration of 75 ng/ml.
RNA labeling
Five micrograms of total RNA were used to synthesize
fluorescently labeled cDNA using the Pronto ChipShot
TM Direct
Labeling Kit (Corning, Avon, France) according to the manufac-
turer’s protocol. Briefly, a reverse transcription reaction was
performed using 1 mL of random primer and 1 mL of oligo(dT)
and then labeled with dyes (Cy
TM Dye Post-labeling Reactive Dye
Pack, GE Healthcare, Buckinghamshire, UK). The labeled cDNA
was purified by application to an equilibrated filter cartridge using
the ChipShot
TM Membrane Clean-Up System (Promega, Madi-
son, WI, USA) following the manufacturer’s recommendations.
Quantity and labeling efficiency of labeled cDNA were deter-
mined by quantifying the absorbance at 260, 550 and 650 nm
using a spectrophotometer NanoDrop
TM (Thermo Scientific,
Palaiseau, France). Each RNA sample was labeled with the dyes
swapped to eliminate artifacts resulting from variation in the
different dyes’ incorporation in the experimental and control
samples.
Microarrays hybridization
Human oligonucleotide microarrays were obtained from
Operon (Operon, Cologne, Germany). The Operon Human
Genome Array-Ready Oligo Set
TM (AROS) Version 4.0 contains
35,035 oligonucleotide probes representing approximately 25,100
unique genes and 39,600 transcripts excluding control oligonu-
cleotides. The human version 4.0 is constructed based on the
Ensembl human database with full coverage of the NCBI human
Refseq dataset. Hybridization of microarrays with fluorescently
labeled cDNA was conducted in a Ventana hybridization system
(Ventana Medical Systems, S.A, Illkirch, France) at 42uC for 8 h.
Slides were subsequently washed twice in 26SSC and 0.16SSC
at room temperature. Buffer remaining on the slide was removed
by rapid centrifugation (4000 g, 15 sec). The fluorescence intensity
was scanned using an Agilent Microarray Scanner G2505B
(Agilent Technologies, Inc., Santa Clara, CA, USA). Microarray
data are being deposit in conformity to MIAME guidelines in the
public ArrayExpress Archive database of microarray gene
expression data at the European Bioinformatics Institute (http://
www.ebi.ac.uk/arrayexpress/).
Data analysis
Image analysis and statistical tests were performed as described
[7]. The signal and background intensity values for each spot in
both channels were obtained using ImaGene 6.0 software
(Biodiscovery, Inc, Proteigene, Saint Marcel, France). The data
were filtered using the ImaGene ‘‘empty spot’’ option that
automatically flags and removes low-expressed and missing spots
from the analysis. After log base 2 transformation, the data were
corrected for systemic dye bias by Lowess normalization using
GeneSight 4.1 software (BioDiscovery, El Segundo, USA).
Statistical analyses were performed using the free R 2.1 software
(http://www.r-project.org) after controlling for the variance of
each gene. The data were analyzed using a standard Student’s t-
test to detect genes that were differentially expressed in the orange
and hesperidin groups as compared to the control group.
Probability values were adjusted using the Bonferroni correction
for multiple testing at 1% to eliminate false positives. Genes
selected by these criteria are referred to as ‘‘differentially expressed
genes’’.
Gene ontology (GO) annotations of biological processes for
differentially expressed genes were conducted using GOstat
(http://gostat.wehi.edu.au) [20]. This program determines all
annotated GO terms for all genes and applies a Fisher’s Exact Test
to evaluate whether the observed difference is significant or not.
The Benjamini and Hochberg correction was also performed to
control the false discovery rate.
Results
Volunteers’ baseline characteristics
Subjects enrolled in the clinical trial study were healthy men
(5661 years old) who were slightly overweight (average BMI of
27.460.3 kg/m
2, Table 1). Subjects ranged from normal to
mildly hyperlipidemic, as calculated from the baseline values for
plasma cholesterol and triglyceride concentrations, and two-thirds
of the subjects were normotensive. The dietary survey, performed
before the study and at the end of each experimental period, did
not reveal any significant changes in food habits throughout the
intervention study. No significant changes in anthropometric and
biochemical parameters (blood lipids, glycemia and insulinemia)
were observed during the entire study period as we previously
reported [1].
Gene expression profiles in leukocytes
RNA from the white blood cells of ten fasted volunteers was
used for the gene microarray study. After paired statistical analysis
followed by false positive correction of the gene expression profiles,
modification of the gene expression profile was observed in blood
cells from volunteers that consumed orange juice or hesperidin+-
control drink in comparison to the placebo+control drink group.
These differentially expressed genes were divided into three
groups: 1) genes that were differentially expressed in the orange
juice consumption group, 2) genes with differential expression in
response to hesperidin consumption and 3) genes that were
differentially expressed in response to both the orange juice and
hesperidin treatments. Using this approach, we identified 3,422
genes as differentially expressed by orange juice (Table S2) and
1,819 genes by hesperidin (Table S3). Among the genes
modulated by orange juice consumption, 1,706 were up-regulated
and 1,716 genes were down-regulated, with an average fold
change of 1.42 and 21.30, respectively. For the hesperidin group,
1,033 genes were upregulated, with an average fold change of
1.34, and 786 genes were down-regulated, with an average fold
change of 21.25. Interestingly, 1,582 of these genes overlapped
Table 1. Baseline characteristics of the entire study
population on the screening day
1.
Mean ± SEM Range
Age (y) 56615 1 – 6 3
Body Mass index (kg/m
2) 27.460.3 25.2–30.5
Systolic Blood Pressure (mmHg) 13463 108–169
Diastolic Blood Pressure (mmHg) 82626 4 – 1 0 9
Triglycerides (mmol/l) 1.4260.14 0.50–2.60
Total Cholesterol (mmol/l) 5.6560.17 4.00–6.70
HDL-cholesterol (mmol/l) 1.4960.05 1.02–1.97
Fasting Glucose (mmol/l) 5.4860.17 4.60–8.80
1n=24. CRP, C-reactive protein.
doi:10.1371/journal.pone.0026669.t001
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similarly down- or up-regulated in the response to both orange
juice and hesperidin (Figure 2). Nevertheless, for hesperidin
group, a slightly lower magnitude of gene expression difference
was observed, as revealed by a reduction of approximately 20–
30% of the fold change when compared to the orange juice group.
To determine the roles of the differentially expressed genes,
genes were classified into functional categories according to their
biological process gene ontology annotations using GOstat
software. Over-represented gene ontologies (GO) for the two
groups are shown in Table S4 and Table S5. Among the GO
terms identified for the orange juice group, more than 70% were
also identified for the hesperidin group. Differentially-expressed
genes, modulated by both orange juice and hesperidin consump-
tion, are involved in different biological processes with the most
over-represented processes being signal transduction, cell adhe-
sion, immune response, cell proliferation, chemotaxis and lipid
metabolism. Some of these processes were over-represented in the
up- or down-regulated genes, (e.g., chemotaxis, cytoskeleton
organization or biogenesis), and the majority of genes were
downregulated. On the other hand, genes implicated in processes
such as the inflammatory response or the I-kappaB kinase/NF-
kappaB cascade were overrepresented in the upregulated genes.
Discussion
In this study, we demonstrated that the consumption of orange
juice or hesperidin for 4-weeks in healthy men affected blood
leukocyte gene expression profiles. Several of these genes are
modulated by both orange juice and hesperidin. Thus, it is
conceivable that hesperidin, a major orange phenol, contributes to
the biological effects of its food carrier. Several of observed
changes in gene expression could be described as anti-inflamma-
tory and anti-atherogenic responses to these dietary interventions.
Gene Ontology analysis of differentially expressed genes
revealed that both orange juice and hesperidin modulated the
expression of numerous genes that are potentially implicated in the
processes of inflammation and atherosclerosis development.
Among them are genes encoding chemokines, such as CCL26,
CX3CR1, or CXCL17, for which expression was downregulated
(Figure 3). Chemokines are chemoattractant cytokines that
regulate leukocyte trafficking and activation [21]. CX3CR1 is
expressed in monocytes and is involved in their recruitment to
atherosclerotic arteries. Increased expression of CX3CR1 has
been observed in foam cells in human atherosclerotic arteries but
not in normal human arterial tissue [22]. Furthermore, a deletion
of CX3CR1 in apoE2/2 mice decreased macrophage accumu-
lation [23]. Both orange juice and hesperidin also downregulated
the expression of CCL26, gene expressed in human monocytic
cells that is regulated by IL-4 [24]. Interestingly, our transcriptome
analysis also showed decreased expression of IL4 in response to
both orange juice and hesperidin. Orange juice modulated the
expression of 9 other genes encoding chemokines and their
receptors. In particular, it downregulated the expression of
monocyte chemoattractant protein-1 (MCP-1 or CCL2), a strong
chemoattractant involved in monocyte/macrophage migration
and infiltration. Plasma levels of CCL2 are higher in patients with
peripheral arterial disease [25]. Inactivation of the MCP-1 gene in
atherosclerosis mouse models resulted in a significant decrease in
lesion size together with lower macrophage infiltration [26]. The
observed downregulation of CCL2 could be in agreement with a
report from a previous clinical trial that showed a decrease in
CCL2 levels after chronic consumption of a polyphenol-rich
sparkling wine [27]. Orange juice consumption also decreased the
expression of other genes known to be highly expressed in human
atheromas throughout all stages of plaque development, such as
CCL21, CXCL11 and CXCL16 [28,29]. These genes encoding
chemokines are regulated by the NFkB transcription factor. Our
microarray analysis also revealed that both orange juice and
hesperidin upregulated the expression of the inhibitor of NFkB
(NFkBIB). This observation suggests that upregulation of the
expression of NFkBIB could, in turn, inhibit NFkB activity and be
related to the observed downregulation of the expression of genes
encoding the chemokines. Interestingly, a bioinformatics analysis
revealed that NFkB (Figure 4) appeared as one of the most
statistically relevant transcription factors for which activity could
be modulated by both orange juice and hesperidin. This finding
seems to be in agreement with previous studies suggesting that
flavonoids might modulate the activity of this transcription factor
and the expression of NFkB-dependent genes [30]. In agreement
with the possible impact of orange juice and hesperidin on NFkB-
dependent genes, we also observed changes in the expression of
several genes encoding adhesion molecules (Figure 3). The
interaction of circulating blood cells with the endothelium is the
first event in atheroma plaque formation and requires the
participation of different adhesion proteins. Both orange juice
and hesperidin downregulated expression of CD80. This regulator
of T-cell activation was found to be upregulated during the
monocyte-endothelial cell interaction [31] as in patients with CVD
[32]. Interestingly, both orange juice and hesperidin induced
expression of BCL6, a transcriptional repressor that prevents the
expression of CD80 by binding to its promoter region [33].
Furthermore, orange juice and hesperidin also induced the
expression of another cell adhesion molecule, CEACAM3 which
inactivation induced neutrophil adhesion to endothelial cells [34].
The transcriptome study also revealed the downregulation of
ITGBL1 by both orange juice and hesperidin, while only orange
juice decreased the expression of several other genes encoding
integrins, such as ITGA5, ITGA7 and ITGAX. It has been shown
that ITGAX deficiency reduced the firm arrest of monocytes on
vascular cells, monocyte/macrophage accumulation in intimae
and consequently, reduced atherosclerosis development in
Figure 2. A Venn diagram of the number of differentially
expressed genes in human blood leukocytes after a 4-week
consumption of orange juice, hesperidin or both. Expression of
these genes was significantly different from the control drink
consumption group.
doi:10.1371/journal.pone.0026669.g002
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modification in expression of the integrin genes, we also observed
expression modulation of genes encoding connexins, known as gap
junction adhesion molecules. For example, both orange juice and
hesperidin downregulated the expression of connexin 31.3 while
connexins 30, 40 and 46 were only downregulated by orange juice.
In response to orange juice or hesperidin consumption, the
combined expression regulation of genes encoding chemokines
and their receptors and adhesion molecules suggests a lower
recruitment and infiltration of circulating cells to the vascular wall.
From our study, a large subset of genes implicated in the
processes of lipid metabolism and transport has been identified as
differentially expressed in response to orange juice and hesperidin
consumption (Figure 3). In particular, we observed a significant
downregulation of LDLR, the receptor responsible for LDL
binding and internalization in macrophages. Inside the cell, free
cholesterol is converted to a cholesteryl ester and forms lipid
droplets due to acylCoA:cholesterol acyltransferase (ACAT)
activity. In our study, ACAT2 was downregulated by orange
juice consumption, suggesting a potential decrease in lipid droplet
accumulation, which could reduce foam cell formation. This
result could be in agreement with a previous study which showed
that flavonoid from grapefruit, naringenin, inhibits ACAT2
activity [36]. Furthermore, macrophage intracellular cholesterol
is regulated by membrane transporters of the ATP-binding
cassette (ABC) superfamily. These proteins are implicated in
reverse cholesterol transport from macrophages, which represents
a potential protective effect against foam cell formation, the
hallmark of atherosclerosis [37]. ABCA2 is one of the most
upregulated genes by both orange juice and hesperidin.
Moreover, both orange juice and hesperidin also induced
expression of the ABCF1 gene, while orange juice up-regulated
other ABC-transporter genes, such as ABCG1 and ABCB5.
Disrupting ABCG1 in mice was observed to promote the
accumulation of excess cholesterol in macrophages [38]. Overall,
the observed decrease in the expression of genes encoding the
LDL receptor and ACAT2 together with an increase in the
expression of genes regulating reverse cholesterol transport
Figure 3. A heat-map of atherosclerosis-related gene expression changes after the consumption of orange juice or hesperidin in all
10 subjects. Red indicates up-regulation and green indicates down-regulation. Statistically significant genes, after a p-value adjustment to minimize
false positives using the Bonferroni correction for multiple testing, are represented by an asterisk.
doi:10.1371/journal.pone.0026669.g003
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into foam cells after 4 weeks of orange juice or hesperidin
consumption.
A comparison of the global nutrigenomic profiles of orange juice
and hesperidin revealed that hesperidin modulated a smaller
number of genes and induced lower fold-changes. This difference
in genomic effect is not surprising as we compared a complex
beverage versus pure hesperidin administered with a control sugar
drink. Nevertheless, the 53% of genes modulated by orange juice
also constitute the potential molecular targets of hesperidin, which
suggests that hesperidin plays an important role in the genomic
effects of this beverage. This finding represents the first evidence of
a role for a polyphenolic compound in the gene-mediated effects of
a complex food in human. Changes in leukocyte gene expression
mediated by hesperidin were observed in fasted subjects while
hesperidin metabolites were no longer present in blood circulation
[39]. This persistent effect at the genomic level could be regarded
as an adaptation of leukocytes to continuous high-flavanone
exposure.
In summary, this study reveals that numerous genes modulated
by orange juice and hesperidin in blood cells are involved in
processes that regulate interactions with the endothelium (adhe-
sion, infiltration) and lipid accumulation (Figure 5). This
nutrigenomic study shows that regular consumption of orange
juice alters gene expression to a potentially protective cardiovas-
cular profile. Furthermore, this work gives insight into the
Figure 4. A representative biological network based on the differentially expressed genes of the orange juice group using
MetaCore
TM network software and the Analyze Network algorithm. The network shown is the NF-kB network. Dots in the right corner of a
gene indicate differential expression.
doi:10.1371/journal.pone.0026669.g004
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vascular-protective effects of citrus fruits in humans.
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